Little is known about how opioid prescriptions for chronic pain are initiated. We sought to describe patterns of prescription opioid initiation, identify correlates of opioid initiation, and examine correlates of receipt of chronic opioid therapy (COT) among veterans with persistent noncancer pain.
C hronic noncancer pain may occur in up to half of patients treated in primary care settings, including veterans. [1] [2] [3] Opioids are among the most commonly used prescription medications for treatment of chronic pain, 4 and in the past few decades, the use of opioids for chronic pain has increased dramatically. Unfortunately, there is little empirical information to guide clinicians regarding when to initiate or to continue opioids for their patients with chronic pain. Organizations have made efforts to develop chronic pain and opioid treatment guidelines. [5] [6] [7] These guidelines advocate for conducting careful assessments, using opioids after other modalities have been tried, and/or as part of a multimodal treatment plan, informing patients of risks and benefits of using opioids, taking extra precautions for patients at high risk for aberrant medication-related behaviors, and monitoring outcomes. Nonetheless, the efficacy and safety of long-term opioid therapy remains unclear. 8, 9 In addition, little is known about the circumstances of opioid initiations for chronic noncancer pain, in particular, which clinicians initiate them and under what clinical circumstances. Some research has examined predictors of initiating and continuing prescription opioids, principally with non-Veterans Affairs (VA) patient populations, and has shown that important predictors include comorbid psychiatric disorders, problem drug use, and nicotine use. [10] [11] [12] [13] A more recent examination of opioid prescription patterns from a large managed care plan in North West Oregon and South West Washington found that psychological distress, unhealthy lifestyles, and health care utilization were incrementally associated with duration of prescription opioids. 14 In 2 recent studies of Operation Enduring Freedom/Operation Iraqi Freedom Veterans treated in the VA health care system, prevalent prescription opioid use was common and associated with psychiatric and nicotine use disorders. 15, 16 In these latter studies, use of concurrent sedative hypnotics was common, multiple prescribers were often involved, and urine drug screening was administered infrequently, suggesting that many of these patients may not be receiving optimal chronic pain care. 7, 17 However, information about incident opioid prescribing was not available in these recent studies.
The objectives of this study were to (1) describe patterns of prescription opioid initiation; (2) identify correlates of prescription opioid initiation; and (3) identify correlates of chronic opioid therapy (COT; > 90 consecutive days) use among Veterans with persistent noncancer pain who received care in a VA regional health care network.
Participants
Potential participants were veterans who received any medical care at VA facilities [Veterans Integrated Service Network (VISN)-20] in the Pacific Northwest (Washington, Oregon, Idaho, and Alaska) during calendar year 2008. Patient data were extracted from the VISN-20 Data Warehouse, which is updated regularly and contains data from the main clinical software packages of regional VA health care facilities and 2 national VA databases. 18 Patients with pain were identified using pain numeric rating scores (NRS) that were obtained as part of routine screening; over 95% of veterans with an outpatient visit in VISN-20 in 2008 had at least 1 NRS score. The NRS rates pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst possible pain. 19 We selected patients who had NRS pain scores Z4 recorded in at least 3 different months during 2008, consistent with common definitions of chronic or persistent pain that require at least 3 to 6 months duration of moderate-to-severe pain. 20 A cutoff of 4 was used for this study because of its consistency with VA clinical practice and policy regarding indication for further evaluation of pain. Scores of 4 are also indicative of moderate-to-severe pain. 7, 21 An index date was calculated for each veteran, defined as the date of the last pain score Z4 in calendar year 2008.
We identified a total of 24,130 veterans in VISN-20 who met our definition for having persistent pain in 2008. After excluding patients with cancer diagnoses (n = 4788), surgery (n = 1298), or participation in a VA opioid substitution programs (n = 408) in the year before or during the 12-month study period, and veterans who died during the study year (n = 510), we were left with 17,126 patients with persistent pain. Of these, 5961 (35%) had not been prescribed any opioid by a VISN-20 clinician in the 12 months before the 2008 index date. Patients who were subsequently prescribed opioids during the 12-month study period after the index date were classified into 2 groups: patients prescribed opioid medications on a short-term basis ( < 90 d) (n = 1767) or patients prescribed opioid medications for 90 or more consecutive days (COT; n = 273). Ninety or more consecutive days has been used as an indicator of COT in earlier studies. 22, 23 Prescriptions for tramadol or buprenorphine were excluded from the study because tramadol has weak opioid activity and in clinical practice is sometimes prescribed for reasons other than treatment of pain; buprenorphine is not US Food and Drug Administration approved for the treatment of pain.
Demographic data included age, sex, race, marital status, and VA service-connected disability status. Diagnoses of common psychiatric and substance use disorders (SUDs; including alcohol abuse/dependence) made by clinicians during health care contacts were collected for the 12 months before the index date. Inpatient and outpatient diagnoses were based on the International Classification of Diseases, Clinical Modification-9th Revision. These diagnoses were also used to calculate a Charlson Comorbidity score, a measure of the overall burden of medical conditions. 24 Body mass index was computed based on height and weight data obtained in proximity to the time of the index date. VA pharmacy data were collected for the 12 months after the index date to obtain information on prescriptions of current opioids and nonopioid analgesics.
Each opioid prescription dose was converted to a morphine equivalent dose. 25 We also collected data on administrations of urine drug tests (UDTs). The lists of International Classification of Diseases, Clinical Modification-9th Revision codes used and specific medications examined in this study may be obtained upon request from the first author.
Statistical Analyses
Patients who were prescribed COT were compared with patients who were prescribed opioids for fewer than 90 days (short-term use) and to patients who did not receive an opioid prescription over the study period. Demographic and diagnostic data were analyzed with w 2 tests for categorical variables and analysis of variance (ANOVA) for continuous variables. Multivariate logistic regression analyses were conducted to evaluate demographic and clinical variables associated with receiving an opioid prescription. These analyses controlled for the effects of age, sex, and baseline pain intensity. Other variables that were entered into the models included diagnoses of major depressive disorder, nicotine dependence, and any SUD (excluding caffeine and nicotine). Variables were included based on the results from the bivariate tests and relationships shown or suggested by prior literature. In some instances, we excluded diagnoses that may be associated with an increased likelihood of receiving a prescription because of a high degree of correlation with variables already included in the model (eg, post-traumatic stress disorder was not included because of its strong correlation with major depressive disorder). In the first model, we evaluated the likelihood of receiving any opioid prescription. For this model, COT and short-term groups were collapsed, and the reference group was comprised of patients who did not receive an opioid prescription. In the second model, we examined factors associated with receiving prescriptions for COT. The reference group was patients who did not receive an opioid prescription and in this model, we did not include patients who received short-term opioid prescriptions.
RESULTS

Patient Characteristics
The majority of the sample was male (90%) and white (86%), and the average age was 56 years. Of the 5961 patients in the sample, 1767 (30%) were prescribed opioids on a short-term ( < 90 d) basis, and 273 (4.6%) were prescribed COT (Z90 d) over the 12-month study period (Table 1) . Patients not prescribed opioids were slightly older than patients prescribed opioids (P < 0.001). COT patients were less likely to be married than patients receiving only short-term or no opioids. (P = 0.007). Otherwise, no significant demographic differences were detected when comparing patients prescribed opioids and patients not prescribed opioids. Table 2 compares clinical pain variables and diagnoses among the 3 groups. The average number of days prescribed opioids in 1 year was 37.4 days (SD = 39.7) for patients prescribed opioids short-term compared with 234.3 days (SD = 75.5) for patients prescribed COT. The COT group was significantly more likely to be diagnosed with every pain condition except fibromyalgia, inflammatory bowel disease, and neuropathy. The prevalence of nicotine use disorder was significantly greater in the COT group compared with the other 2 groups. Similarly, rates of mental disorder diagnoses were significantly higher in the COT group for major depressive disorder, posttraumatic stress disorder, SUD (which included alcohol abuse/dependence), and sleep disorders. The Charlson Comorbidity Score was higher in the COT group and the short-term use group compared with the nonopioid users (P < 0.001). Patients prescribed COT also had a greater average reported pain intensity at their index dates compared with patients prescribed opioids short-term or patients not prescribed opioids (P = 0.01).
We examined the source of first opioid prescriptions among patients receiving opioid prescriptions ( Fig. 1 ). Among those with any opioid prescription, 46 of 2040 (2%) had their first opioid prescriptions written during the study period while inpatients, and within the COT group, 3 of 273 (1%) had them written while they were inpatients. Forty-six percent of patients who received any opioid received their first outpatient prescription from primary care clinicians, whereas 69% of COT patients received their first outpatient prescriptions from primary care clinicians. Emergency room clinicians were the second most common source of initial prescriptions for patients receiving any opioid (23%), and for patients receiving COT (13%).
Among the patients who received any opioid prescription, patients receiving only short-term prescriptions received slightly lower average daily morphine equivalent doses than those who received COT [23.1 mg (SD = 22.2) vs. 26.4 mg (SD = 22.1); P = 0.026]. The range of average morphine equivalent dose for acute users was 2.5 to 167 mg/ d compared with 4 to 174 mg/d for COT users. The most commonly prescribed opioid for both groups was hydrocodone followed by oxycodone ( Table 3 ). The majority of wPain is rated on a scale of 0 to 10 numerical rating system, with 0 representing no pain and 10 representing the worst possible pain. short-term users were prescribed a short-acting opioid (98.2%) and few short-term users were prescribed a longacting opioid (5.7%). Among patients receiving COT, 93% were prescribed at least 1 short-acting opioid and 29.3% were prescribed at least 1 long-acting opioid. Patients receiving COT were more likely to be prescribed a combination of a short-acting and long-acting opioid (22.3% vs. 3.9%, P < 0.001).
The proportions of chronic non-cancer pain patients receiving various nonopioid but often-used medications for pain are shown in Figure 2 . Short-term opioid and COT patients were prescribed nonsteroidal anti-inflammatory medications or acetaminophen more frequently than nonopioid users. Anticonvulsants and antidepressants were more frequently prescribed to COT patients compared with short-term users and nonopioid users. Benzodiazepine prescriptions were prescribed more frequently to COT patients than to short-term and nonopioid patients [23.8% vs. 15.7% and 11.5%, w 2 (2) = 46.5; P < 0.001]. There was an increased frequency of urine drug screens administered to COT patients (37%) compared with patients prescribed opioids short-term (23%), or patients not prescribed opioids [16%, w 2 (2) = 96.8; P < 0.001]. Among patients who had at least 1 UDT, there was no difference between groups in the likelihood of having a positive screen for illicit substances [9% vs. 5% and 8%, w 2 (2) = 3.3, P = 0.19].
Tables 4 and 5 display the results of the logistic regression analyses examining factors associated with receipt of opioid prescriptions over the study period. In the first model, after adjusting for age, sex, and baseline pain intensity score, previous year diagnosis of substance disorder [odds ratio (OR) = 1.19, 95% confidence interval (CI), 1.03-1.38] and diagnosis of major depressive disorder (OR = 1.13, 95% CI, 1.00-1.26) were significantly associated with greater odds of being prescribed any opioid over the study period. In the second model, which evaluated the likelihood of receiving COT, being male (OR = 1.84, 95% CI, 1.11-3.05), baseline pain intensity scores (OR = 1.11, 95% CI, 1.03-1.19), and diagnoses of nicotine dependence (OR = 1.59, 95% CI, 1.21-2.10), SUD (OR = 1.49, 95% CI, 1.09-2.02), and major depressive disorder (OR = 1.35, 95% CI, 1.04-1.75) were each associated with greater odds of receiving COT.
DISCUSSION
We found that about one third of the veterans with persistent pain who were not prescribed opioids in 2008 received 1 or more opioid prescriptions in the subsequent 12 months. In adjusted models, diagnoses of SUD and major depression were associated with receiving any opioid prescription. Only 5% of patients with persistent pain went on to receive COT. Most initial opioid prescriptions preceding COT were written by primary care clinicians. Male sex, greater baseline pain intensity, nicotine dependence, SUD, and major depression diagnoses were associated with COT initiations. Of the patients prescribed COT, less than one third were prescribed long-acting opioids, one third were administered 1 or more UDTs, and one quarter were prescribed benzodiazepines.
Our results are generally consistent with earlier studies of primarily non-VA patient populations showing that prescription opioid use is associated with comorbid psychiatric disorders including SUDs and nicotine. 10, 11, 13, 15, 16, [26] [27] [28] This is noteworthy considering that chronic pain treatment guidelines emphasize the need to exercise special caution when treating patients with SUD. An additional study 12 showed that patients with painful lumbar spine conditions self-reported 12-month incident prescribing rates of 8%, and another study 29 conducted at 2 large Pacific Northwest health plans showing 1-year incident rates of long-term prescription opioid use (defined similarly as in our study) ranged from 6.3 to 12.1 per 1000. Although the rates of incident prescribing found in these latter studies are lower than the rates we found, we used a study sample whose members had moderate to severe persistent pain at baseline as opposed to a sample of patients who may or may not have had pain at baseline.
The mechanisms underlying the relationship between psychiatric disorders and prescription opioid use are not clear. Mental disorders have been associated with a higher prevalence of various somatic symptoms including pain, 30 and it is possible that in some cases opioids are used to treat poorly differentiated constellations of pain and emotional symptoms. 31 Indeed, Turk and Okifuji 32 found, in a study of 191 patients from a multidisciplinary pain facility, that patients' nonverbal communications of pain, distress, and suffering were the primary predictors of physician opioid prescribing behavior. Furthermore, although the relationship between nicotine and pain and prescription opioid use has been well documented, the mechanisms underlying this relationship are not clear. Nicotine may be a marker for SUD or other psychiatric disorder, or there may be alterations in pain processing due to exposure to chronic cigarette smoke and nicotine's analgesic properties resulting in cross-tolerance with opioids. 33 In our study, we found that nicotine dependence remained significantly associated with opioid prescription in a model including SUD and major depression, suggesting that nicotine use may have an independent effect on opioid initiation. We found mixed results regarding the extent to which patients initiating opioids receive care that is optimally safe and effective. Pain treatment guidelines frequently recommend, in coordination with clinical judgment, that when pain is persistent, long-acting opioids be considered to minimize the use of concurrent sedative-hypnotics, and to use UDTs for selected patients. 6, 34 Possible theoretical advantages of long-acting opioids include more stable opioid levels, increased tolerance to adverse effects, and reduced reinforcement of pain behaviors. 35 Yet there is little empiric evidence to support the use of long-acting over short-acting opioids, 36 and clinicians may consider this lack of evidence when prescribing opioids. In our sample, 29% of patients prescribed COT received a long-acting opioid. Furthermore, 24% of patients prescribed COT received concomitant benzodiazepine medications, which is concerning given that overdose deaths (including those related to opioids) have been linked to the use of multiple sedating medications. [37] [38] [39] We also found the rate of UDTs to be relatively low. It has been suggested that patients have UDTs before opioid initiation and receive regular monitoring. Certainly, patients considered "high risk" should receive UDTs more frequently. Although this concept of risk has not been welldefined, given the high rate of comorbid SUDs among patients with chronic pain, 40 and that 29% of patients in the current sample receiving COT were diagnosed with a SUD, these data support earlier studies showing that UDS is underused. [41] [42] [43] Finally, patients who received opioids were more likely to receive adjuvant pain medications. Although this is consistent with recommendations that opioids be used as one part of a comprehensive plan containing nonmedication and nonopioid medication components, it may also reflect the medical and psychiatric complexity of patients who may be refractory to, or who have had multiple trials of, nonopioid pain treatment.
We found that although slightly less than half of opioid prescriptions used short term were written by primary care providers, two thirds of opioid prescriptions resulting in COT were initiated by primary care providers. This is important because pain treatment guidelines often advise that opioids be initiated only after trials of nonopioid medications, as part of a comprehensive pain treatment strategy, and framed as a trial dependent on monitoring outcomes over time. 6, 34 Although this treatment approach may be feasible in primary care settings, it would be less practical if most opioid prescriptions were started in emergency rooms or inpatient settings. The finding that opioids are primarily initiated in primary care supports the development of guidelines geared toward primary care practice. It also supports the feasibility of providing interventions and structures in primary care that facilitate proactive planning around opioid use and its monitoring.
Several limitations should be considered when interpreting the results of this study. This was a retrospective study using administrative data. Participants were predominantly male, white veterans receiving VA health care in the Pacific Northwest portion of the United States; generalizability to patients in other regions or outside of the VA may be limited. Our findings are dependent on the extent, accuracy, and validity of the data available in the VA administrative dataset. For example, as prescription medication information was obtained from administrative data, we were not able to evaluate patient adherence to prescribed medications. It is also difficult to distinguish between the use of 2 medications simultaneously versus sequential use of 2 medications, and we could not determine the reasons particular adjunctive medications (eg, antidepressants) were prescribed. It is also possible that the group of veterans who did not receive opioids in the full year before the index date were different from other patients who would otherwise have received opioids earlier in their pain care-perhaps this group of Veterans were more likely to be opioid averse. This could help to explain why the COT initiation rate was only 5% over the study period. An alternative method of examining factors associated with opioid initiations would be to examine incident prescribing among the larger group of veterans, not just those with persistent pain. Patients may have received opioids from a non-VA provider, which would not be detectable in these analyses. Finally, we did not assess the use of nonpharmacologic treatments for pain, which may have been associated with opioid prescribing patterns and have clinical implications. 
